Flashback to 2023!
There have been significant advancements in 2023, aligned with the models performed at Epistem. Our dedicated scientific team always reviews the latest standout publications...
There have been significant advancements in 2023, aligned with the models performed at Epistem. Our dedicated scientific team always reviews the latest standout publications...
Epistem’s team of experts will be exhibiting at Booth 3132! We will also present some of our preclinical work in IBD. If you would like...
Epistem Limited, a UK-based pre-clinical and clinical research services company, has expanded its in vitro model portfolio through an agreement with Hubrecht Organoid Technology (HUB). The...